Search Results - "Hull, MA"

Refine Results
  1. 1

    Cyclooxygenase-2: How good is it as a target for cancer chemoprevention? by Hull, Mark A.

    Published in European journal of cancer (1990) (01-09-2005)
    “…There is now substantial evidence for a role for cyclooxygenase-2 (COX-2)-mediated prostaglandin (PG) signalling during carcinogenesis in a number of tissues…”
    Get full text
    Journal Article
  2. 2

    The omega‐3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC‐26 colorectal cancer cell liver metastasis via inhibition of PGE2‐dependent cell motility by Hawcroft, G, Volpato, M, Marston, G, Ingram, N, Perry, SL, Cockbain, AJ, Race, AD, Munarini, A, Belluzzi, A, Loadman, PM, Coletta, PL, Hull, MA

    Published in British journal of pharmacology (01-07-2012)
    “…BACKGROUND AND PURPOSE The omega‐3 polyunsaturated fatty acid (PUFA) eicosapentaenoic acid (EPA) has antineoplastic activity at early stages of colorectal…”
    Get full text
    Journal Article
  3. 3

    Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England by Burr, Nicholas E., Smith, Chris, West, Robert, Hull, Mark A., Subramanian, Venkataraman

    Published in Clinical gastroenterology and hepatology (01-04-2018)
    “…The prescription of opiate medications is increasing. Individuals with inflammatory bowel diseases (IBD) can develop serious complications from opiate use, but…”
    Get full text
    Journal Article
  4. 4

    Increased Risk of Colorectal Cancer After Obesity Surgery by Derogar, Maryam, Hull, Mark A, Kant, Prashant, Östlund, Magdalena, Lu, Yunxia, Lagergren, Jesper

    Published in Annals of surgery (01-12-2013)
    “…OBJECTIVE:The purpose was to determine whether obesity surgery is associated with a long-term increased risk of colorectal cancer. BACKGROUND:Long-term cancer…”
    Get full text
    Journal Article
  5. 5

    Obesity surgery and risk of colorectal and other obesity-related cancers: An English population-based cohort study by Aravani, Ariadni, Downing, Amy, Thomas, James D., Lagergren, Jesper, Morris, Eva J.A., Hull, Mark A.

    Published in Cancer epidemiology (01-04-2018)
    “…•The association between obesity surgery (OS) and cancer risk remains unclear.•Colorectal cancer (CRC) risk is increased in obese individuals.•No evidence of…”
    Get full text
    Journal Article
  6. 6

    Colorectal Cancer Prognosis Following Obesity Surgery in a Population-Based Cohort Study by Tao, Wenjing, Konings, Peter, Hull, Mark A., Adami, Hans-Olov, Mattsson, Fredrik, Lagergren, Jesper

    Published in Obesity surgery (01-05-2017)
    “…Background Obesity surgery involves mechanical and physiological changes of the gastrointestinal tract that might promote colorectal cancer progression. Thus,…”
    Get full text
    Journal Article
  7. 7

    The omega‐3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC‐26 colorectal cancer cell liver metastasis via inhibition of PGE 2 ‐dependent cell motility by Hawcroft, G, Volpato, M, Marston, G, Ingram, N, Perry, SL, Cockbain, AJ, Race, AD, Munarini, A, Belluzzi, A, Loadman, PM, Coletta, PL, Hull, MA

    Published in British journal of pharmacology (01-07-2012)
    “…BACKGROUND AND PURPOSE The omega‐3 polyunsaturated fatty acid (PUFA) eicosapentaenoic acid (EPA) has antineoplastic activity at early stages of colorectal…”
    Get full text
    Journal Article
  8. 8

    Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer? by Hull, Mark A, Ko, Stanley C W, Hawcroft, Gillian

    Published in Molecular cancer therapeutics (01-08-2004)
    “…The importance of the prostaglandin (PG) synthesis pathway, particularly the rate-limiting enzymatic step catalyzed by cyclooxygenase, to colorectal…”
    Get full text
    Journal Article
  9. 9

    The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action by Smith, M.-L, Hawcroft, G, Hull, M.A

    Published in European journal of cancer (1990) (01-03-2000)
    “…Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit proliferation and induce apoptosis in human colorectal cancer cells in vitro. It remains unclear whether…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases by Fenwick, Stephen W., Toogood, Giles J., Lodge, J.Peter A., Hull, Mark A.

    Published in Gastroenterology (New York, N.Y. 1943) (01-09-2003)
    “…Background & Aims : Cyclooxygenase-2 (COX-2) is a potential target for chemotherapy of colorectal cancer (CRC). We tested the antineoplastic activity of the…”
    Get full text
    Journal Article
  12. 12

    Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas by Cuthbert, R.J, Wilson, J.M, Scott, N, Coletta, P.L, Hull, M.A

    Published in European Journal of Cancer (01-06-2009)
    “…Abstract CD74 (major histocompatibility complex (MHC) Class II invariant chain) has recently been identified as the cell-surface receptor for the…”
    Get full text
    Journal Article
  13. 13

    Localization of Cyclooxygenase-2 in Human Sporadic Colorectal Adenomas by Chapple, Keith S., Cartwright, Elizabeth J., Hawcroft, Gillian, Tisbury, Alison, Bonifer, Constanze, Scott, Nigel, Windsor, Alistair C.J., Guillou, Pierre J., Markham, Alexander F., Coletta, P. Louise, Hull, Mark A.

    Published in The American journal of pathology (01-02-2000)
    “…A putative target for the anti-colorectal cancer action of nonsteroidal anti-inflammatory drugs is the inducible isoform of cyclooxygenase (COX), COX-2. COX-2…”
    Get full text
    Journal Article
  14. 14

    Effect of nonsteroidal anti-inflammatory drugs on β-catenin protein levels and catenin-related transcription in human colorectal cancer cells by GARDNER, S. H, HAWCROFT, G, HULL, M. A

    Published in British journal of cancer (05-07-2004)
    “…Elevated beta-catenin levels in human colorectal cancer (CRC) cells lead to increased trans-activation of 'protumorigenic' beta-catenin/T-cell factor (TCF)…”
    Get full text
    Journal Article
  15. 15

    Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer by Hull, M.A, Gardner, S.H, Hawcroft, G

    Published in Cancer treatment reviews (01-08-2003)
    “…A substantial body of evidence from rodent colon carcinogenesis models, in vitro experiments with human colorectal cancer cells and limited clinical…”
    Get full text
    Journal Article
  16. 16

    Nonprofits and C Corporations: Performance Comparison by Hull, Robert Martin

    Published in International journal of financial studies (01-01-2023)
    “…We extend the performance comparison study of nonprofits (NPs) and pass-throughs by examining large NPs and large C corporations (CCs). Unlike that study, we…”
    Get full text
    Journal Article
  17. 17

    Indomethacin induces differential expression of β-catenin, γ-catenin and T-cell factor target genes in human colorectal cancer cells by Hawcroft, Gillian, D'Amico, Mark, Albanese, Chris, Markham, Alexander F., Pestell, Richard G., Hull, Mark A.

    Published in Carcinogenesis (New York) (01-01-2002)
    “…Indomethacin-induced G1 arrest and apoptosis of human colorectal cancer (CRC) cells is associated with a dose-dependent decrease in β-catenin protein levels…”
    Get full text
    Journal Article
  18. 18

    Fulminant Crohn’s colitis after allogeneic stem cell transplantation by Sonwalkar, S A, James, R M, Ahmad, T, Zhang, L, Verbeke, C S, Barnard, D L, Jewell, D P, Hull, M A

    Published in Gut (01-10-2003)
    “…We report a case of fulminant Crohn’s colitis that occurred following non-myeloablative allogeneic stem cell transplantation for Hodgkin’s lymphoma. Adoptive…”
    Get full text
    Journal Article
  19. 19

    Two documents by Chin-Yee, Benjamin Hull, BSc MA

    “…The author was struck by two documents in his grandfather's possession. The first, a photograph of his mother -- his great-grandmother. The photograph is not…”
    Get full text
    Journal Article
  20. 20

    Lack of interleukin-4 receptor α chain-dependent signalling promotes azoxymethane-induced colorectal aberrant crypt focus formation in Balb/c mice by Ko, CWS, Cuthbert, RJ, Orsi, NM, Brooke, DA, Perry, SL, Markham, AF, Coletta, PL, Hull, MA

    Published in The Journal of pathology (01-04-2008)
    “…Interleukin (IL)-4 receptor (IL-4R) α chain-dependent signalling by IL-4 and IL-13 promotes tumour growth and metastasis in mouse models of colorectal cancer…”
    Get full text
    Journal Article